Procaps Group (PROC) Announces Chairman Resignation
Get Alerts PROC Hot Sheet
Join SI Premium – FREE
Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that Mr. Ruben Minski has resigned from his role as Executive Chairman of the Board, effective June 30th. Mr. Minski will continue to serve as a member of the Board of Directors.
Reflecting on his decision, Ruben stated: “This month marked six months since Jose Antonio Vieira assumed the role of CEO of Procaps. To ensure a smooth and effective transition, I have had the privilege of serving as Executive Chairman of our Board. Reflecting on these six months, I believe the transition to our new leader has been successful, and it is now time for me to step down from this honorable position. As a major shareholder, I will remain on the Board of Directors to support our efforts to overcome obstacles and capitalize on opportunities.”
The Board of Directors of the Company (the “Board”) has appointed Mr. José Minski, currently a member of the Board and Chair of the M&A Committee, as the new Chairman of the Board.
José Minski brings extensive experience and a deep understanding of Procaps´ strategic direction and operational objectives, which will be invaluable in his new role. José Minski stated, “I am honored to take on this new role and look forward to working closely with the Board and management team to continue driving Procaps´ strategic initiatives and deliver value to our shareholders.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CalPrivate Bank names Andra Frazier as chief credit officer
- BD names Gary Sorsher as chief quality officer, replacing retiree
- Deluxe names Celero Commerce founder as Merchant Services president
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share